Drug intelligence / Profile preview

tazarotene + betamethasone dipropionate

Development stage
Phase 4
Lead developer
Chongqing Huapont Pharmaceutical
Modality
Small Molecules
Administration
Topical
01

Overview

Lefusong is a topical combination therapy developed by Chongqing Huabang Pharmaceutical for the treatment of chronic plaque psoriasis. It contains tazarotene, a third-generation retinoid, and betamethasone dipropionate, a potent synthetic corticosteroid. Tazarotene acts as a selective agonist for retinoic acid receptors (RARs), specifically RAR-beta and RAR-gamma, which helps normalize keratinocyte differentiation and reduce epidermal hyperplasia. Betamethasone dipropionate acts as a glucocorticoid receptor agonist, providing anti-inflammatory, antipruritic, and immunosuppressive effects by inhibiting the release of inflammatory mediators. The combination is designed to enhance efficacy while potentially mitigating the irritation often associated with retinoid monotherapy.

Brand names
Lefusong
Other names
Tazarotene and Betamethasone Dipropionate Cream
02

Targets

GR (Glucocorticoid receptor)RARB (Retinoic acid receptor beta)RARG (Retinoic acid receptor gamma)

Beyond the preview

Go deeper on tazarotene + betamethasone dipropionate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tazarotene + betamethasone dipropionate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call